This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Bayer Aktiengesellschaft, The Broad Institute, Inc.. Active years: 2025.
Company Filing History:
1 out of 12,266 
1 out of 482 
Years Active: 2025
Title: Jacob Jaffe: Innovator in Cancer Treatment
Introduction
Jacob Jaffe is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work has led to the creation of a patent that holds promise for improving cancer therapies.
Latest Patents
Jacob Jaffe holds a patent for "Acyl sulfonamides for treating cancer." This invention provides acyl sulfonamide compounds of general formula (I), which are designed to target and treat cancer effectively. His patent represents a crucial step forward in the ongoing battle against this disease, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Jacob has worked with prominent organizations, including Bayer Aktiengesellschaft and The Broad Institute, Inc. His experience in these esteemed institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Jacob has had the opportunity to work alongside talented individuals such as Léa Aurelie Bouché and Daniel Korr. These collaborations have enriched his research and expanded the impact of his inventions in the scientific community.
Conclusion
Jacob Jaffe's innovative work in developing acyl sulfonamides for cancer treatment highlights his dedication to improving healthcare outcomes. His contributions to the field of oncology are commendable and reflect the importance of continued research and innovation in medicine.